In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b

Clinical and Experimental Immunology

Volumn 153, Issue 2, 2008, Pages 196-204

  Paulsson, J M ^a   Dadfar, E ^a   Held, C ^b   Jacobson, S H ^c   Lundahl, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Chemokines and transmigration; Coronary artery disease; Inflammation; Monocytes

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 4;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL WALL; CELL INFILTRATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; MALE; MONOCYTE; PRIORITY JOURNAL;

AGED; ANTIGENS, CD11B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLISTER; CASE-CONTROL STUDIES; CELL MOVEMENT; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNIZATION; INTEGRIN ALPHA4BETA1; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47249092867     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03676.x     Document Type: Article

References (31)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6:508 19.
2. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986 6:131 8.
3. Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol 2002 160:2145 55.
4. Cushing SD, Berliner JA, Valente AJ et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990 87:5134 8.
5. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991 88:1121 7.
6. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003 170:191 203.
7. Meisel SR, Shapiro H, Radnay J et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol 1998 31:120 5.
8. van Royen N, Hoefer I, Bottinger M et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ Res 2003 92:218 25.
9. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 2002 22:443 9.
10. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 2004 101:11779 84.
11. Randolph GJ, Furie MB. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J Exp Med 1996 18:451 62.
12. Thylen P, Lundahl J, Fernvik E, Gronneberg R, Hallden G, Jacobson SH. Impaired monocyte CD11b expression in interstitial inflammation in hemodialysis patients. Kidney Int 2000 57:2099 106.
13. Follin P. Skin chamber technique for study of in vivo exudated human neutrophils. J Immunol Methods 1999 232:55 65.
14. Scheja A, Forsgren A. A skin chamber technique for leukocyte migration studies; description and reproducibility. Acta Pathol Microbiol Immunol Scand 1985 93:25 30.
15. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007 192:328 34.
16. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 2004 172:7684 93.
17. Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995 154:4157 65.
18. Dadfar E, Jacobson SH, Lundahl J. Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production. Clin Exp Immunol 2007 148:573 82.
19. Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA Jr. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991 147:883 92.
20. Mosedale DE, Smith DJ, Aitken S et al. Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. Atherosclerosis 2005 183:268 74.
21. Martinovic I, Abegunewardene N, Seul M et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005 69:1484 9.
22. Rothenbacher D, Muller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006 26:194 9.
23. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002 23:541 8.
24. Ehrchen J, Steinmuller L, Barczyk K et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007 109:1265 74.
25. Evans BJ, McDowall A, Taylor PC, Hogg N, Haskard DO, Landis RC. Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response. Blood 2006 107:3593 9.
26. Hyduk SJ, Chan JR, Duffy ST et al. Phospholipase C, calcium, and calmodulin are critical for alpha4beta1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants. Blood 2007 109:176 84.
27. Jiang Y, Zhu JF, Luscinskas FW, Graves DT. MCP-1-stimulated monocyte attachment to laminin is mediated by beta 2-integrins. Am J Physiol 1994 267:1112 18.
28. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005 95:452 6.
29. Luo Y, Jiang D, Wen D, Yang J, Li L. Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin. Heart Vessels 2004 19:257 62.
30. Veillard NR, Braunersreuther V, Arnaud C et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 2006 188:51 8.
31. Li JJ, Li YS, Fang CH et al. Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina. Heart 2006 92:529 30.